|
|
Science Sparks @ ACTREC
|
28th October 2024 |
Vol. No. 13 ; Issue No.654 |
|
Publications
|
1. Uchinami Y, Dasgupta A, Nishioka K, Handoko, Goda JS, Kim JW, Zaid RM, Kai Yun O, Mehmood H, Chitapanarux I, Chopra S, Aoyama H. Patterns of Care for Brain Metastases in Asia: A real-world survey conducted by the federation of asian organizations for radiation oncology. JCO Global Oncology. 10:e2400222
2. Giri S, Harindranath S, Mohan BP, Jearth V, Varghese J, Kozyk M, Kale A, Sundaram S. Adverse events with endoscopic ultrasound-guided gastroenterostomy for gastric outlet obstruction-A systematic review and meta-analysis. United European Gastroenterology Journal. 12(7):879-890.
3. Ambulkar R, Solanki SL, Salunke B, Ps P, Gholap S, Desouza AL, Bakshi SG, Agarwal V (2024). A randomised comparison of transverse abdominal plane block versus thoracic epidural analgesia on postoperative opioid consumption for colorectal enhanced recovery after surgery programme (OPIATE study). Journal of Perioperative Practice.
Theses
Kalyani Abhiram Natu. 2024. Investigating the molecular basis of cFLIP/calmodulin interaction for modulating apoptosis. (LIFE09201704018) (Guide: Dr. Kakoli Bose)
|
|
|
Interesting Reads
|
Jiang H, Gao B, Meng Z, Wang Y, Jiao T, Li J, Li X, Cao Y, Zhang X, Li C, Lu S. Integrative multi-omics analysis reveals the role of tumor-associated endothelial cells and their signature in prognosis of intrahepatic cholangiocarcinoma. Journal of Translational Medicine. 22(1):948, 2024.
|
|
Video of the Week
|
|
Alarming Rise of Cancer Cases Among the Younger Generation: Say No To Tobacco |
|
|
|
|
|
|
Do You Know?
In 2014, Pembrolizumab (Keytruda) became the first PD-1-targeting immune checkpoint inhibitor approved by FDA.
|
|
|
Cancer News
|
|
Cutting off cancer cells' access to fats may enhance cancer therapy.
|
News-Medical, 22/10/2024
|
The study focused on ferroptosis, a type of cell death that occurs when fat molecules in cancer cells experience damage. In recent years, targeting ferroptosis has emerged as an increasingly promising avenue for developing new anti-cancer strategies...
|
|
|
|
|
|
|
|
|
|
2024 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|